H. AKBULUT Et Al. , "Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , vol.33, Illinois, United States Of America, 2015
AKBULUT, H. Et Al. 2015. Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , (Illinois, United States Of America).
AKBULUT, H., Gercik, O., Icli, F., Mizrak, D., DEMİRKAZIK, A., Onur, H., ... Senler, F. C.(2015). Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America
AKBULUT, HAKAN Et Al. "Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 2015
AKBULUT, HAKAN Et Al. "Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America, 2015
AKBULUT, H. Et Al. (2015) . "Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={HAKAN AKBULUT Et Al. }, title={Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer}, city={Illinois}, country={United States Of America}, year={2015}}